Medicofarma Biotech SA (WSE:MDB)
0.3750
-0.0070 (-1.83%)
At close: Jan 5, 2026
Medicofarma Biotech Market Cap
Medicofarma Biotech has a market cap or net worth of 25.49 million as of January 7, 2026. Its market cap has decreased by -0.53% in one year.
Market Cap
25.49M
Enterprise Value
28.78M
Revenue
281.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since January 30, 2009, Medicofarma Biotech's market cap has increased from 6.50M to 25.49M, an increase of 292.18%. That is a compound annual growth rate of 8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 38.07M | 40.35% |
| Dec 30, 2025 | 27.12M | 2.84% |
| Dec 30, 2024 | 26.38M | -64.24% |
| Dec 29, 2023 | 73.76M | -6.06% |
| Dec 30, 2022 | 78.51M | -32.05% |
| Dec 30, 2021 | 115.54M | 483.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.73B |
| Synektik Spólka Akcyjna | 2.44B |
| Voxel | 1.35B |
| Celon Pharma | 1.12B |
| Selvita | 805.81M |
| Ryvu Therapeutics | 635.80M |
| Centrum Medyczne ENEL-MED | 509.05M |